Literature DB >> 32928715

A computed tomography study of coronary access and coronary obstruction after redo transcatheter aortic valve implantation.

Nicola Buzzatti1, Matteo Montorfano, Vittorio Romano, Ole De Backer, Lars Søndergaard, Liesbeth Rosseel, Pal Maurovich-Horvat, Julia Karady, Béla Merkely, Bernard D Prendergast, Michele De Bonis, Antonio Colombo, Azeem Latib.   

Abstract

AIMS: The aim of this study was to investigate the risk of impaired coronary access and coronary obstruction after redo TAVI. METHODS AND
RESULTS: Post-procedure multidetector computed tomography (MDCT) scans of 221 TAVI recipients were analysed. Increased risk of impaired coronary access was defined as a coronary ostium below the TAVI commissures with a valve-to-aorta distance <2 mm at this level. Increased risk was found in 123 (55.6%) cases: the left main was involved in 109 (49.3%), the right coronary in 79 (35.7%), and both were involved in 65 (29.4%) patients. A small sinotubular junction (STJ width OR 0.68, CI: 0.56-0.81, p<0.001; STJ height OR 0.81, CI: 0.69-0.95, p<0.011) and supra-annular devices (OR 19.8, CI: 6.6-58.8, p<0.001) predicted increased risk. Increased risk of coronary obstruction, defined as a coronary ostium below the TAVI commissures with a valve-to-coronary distance <2 mm, was observed in 14.9% of patients; in 17.2% of cases complete sealing of the STJ would occur.
CONCLUSIONS: Post-TAVI MDCT suggested an increased potential risk of impaired coronary access in more than half of the patients should redo TAVI be required, predicted by a small STJ and supra-annular device design. Furthermore, 10-20% of patients presented an increased risk of coronary obstruction. While this theoretical study is hypothesis-generating, it raises concerns that need to be further investigated and addressed before TAVI is extended to patients with longer life expectancy.

Entities:  

Mesh:

Year:  2020        PMID: 32928715     DOI: 10.4244/EIJ-D-20-00475

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  4 in total

Review 1.  How to Image and Manage Prosthesis-Related Complications After Transcatheter Aortic Valve Replacement.

Authors:  Nina C Wunderlich; Jörg Honold; Martin J Swaans; Robert J Siegel
Journal:  Curr Cardiol Rep       Date:  2021-07-01       Impact factor: 2.931

2.  Early Acurate Neo transcatheter heart valve degeneration in a haemodialysis patient successfully managed with Sapien 3 Ultra: a case report.

Authors:  Panagiotis Savvoulidis; Adnan Nadir; Peter F Ludman; Sagar N Doshi
Journal:  Eur Heart J Case Rep       Date:  2022-07-01

3.  Outcomes of transcatheter aortic valve replacement for pure native aortic regurgitation with the use of newer- vs. early-generation devices.

Authors:  Wei-Hsian Yin; Yung-Tsai Lee; Tien-Ping Tsao; Kuo-Chen Lee; Ming-Chon Hsiung; Jeng Wei
Journal:  Ann Transl Med       Date:  2022-01

4.  Coronary access following ACURATE neo implantation for transcatheter aortic valve-in-valve implantation: Ex vivo analysis in patient-specific anatomies.

Authors:  Arif A Khokhar; Francesco Ponticelli; Adriana Zlahoda-Huzior; Kailash Chandra; Rossella Ruggiero; Marco Toselli; Francesco Gallo; Alberto Cereda; Alessandro Sticchi; Alessandra Laricchia; Damiano Regazzoli; Antonio Mangieri; Bernhard Reimers; Simone Biscaglia; Carlo Tumscitz; Gianluca Campo; Ghada W Mikhail; Won-Keun Kim; Antonio Colombo; Dariusz Dudek; Francesco Giannini
Journal:  Front Cardiovasc Med       Date:  2022-09-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.